08/14/2024 6:48 AM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 7:41 AM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2024 6:25 AM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form DEF 14A | |
05/15/2024 4:19 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2024 11:15 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form EFFECT | |
05/01/2024 5:02 AM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 3:18 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
|
04/17/2024 8:38 PM | Outlook Therapeutics, Inc. (Subject) Outlook Therapeutics (Subject) Syntone Ventures LLC (Filed by)
| Form SC 13D/A | |
04/17/2024 7:21 PM | Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer) Syntone Ventures LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 4:21 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
04/15/2024 3:53 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/12/2024 3:27 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 424B5 | |
04/07/2024 11:15 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form EFFECT | |
04/02/2024 3:15 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 11:15 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form EFFECT | |
04/01/2024 3:53 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 424B3 | |
03/29/2024 1:16 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/29/2024 9:39 AM | Haddadin Yezan Munther (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 3:00 PM | Outlook Therapeutics, Inc. (Subject) Outlook Therapeutics (Subject) TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
03/26/2024 3:20 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 3:11 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/22/2024 4:00 PM | KENYON LAWRENCE A (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:00 PM | Evanson Jeff (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:00 PM | Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer) TRENARY C RUSSELL III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:24 PM | GMS Ventures & Investments (Filed by) Outlook Therapeutics, Inc. (Subject) Outlook Therapeutics (Subject)
| Form SC 13D/A | |
03/20/2024 4:20 PM | GMS Ventures & Investments (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer) Sukhtian Ghiath M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 4:14 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 3:43 PM | Evanson Jeff (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 3:18 PM | Huang Andong (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 5:59 AM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form DEF 14A | |
02/08/2024 6:00 AM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form ARS | |
01/24/2024 5:02 AM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/22/2023 4:00 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
12/06/2023 4:00 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 7:12 AM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 4:00 PM | Outlook Therapeutics, Inc. (Filer) Outlook Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 7:16 AM | Gangolli Julian S (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/05/2023 4:13 PM | Auffarth Gerd (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/05/2023 4:14 PM | Huang Andong (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/05/2023 4:15 PM | Haller Julia A (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/05/2023 4:05 PM | HILZINGER KURT J (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
NOTICE: You have until Tuesday, November 19th (Ad) On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall...
It's part of a unique strategy which has nothing to do with risky investments like options, cryptos or forex.
And while it might sound crazy... Click here for the ticker >>> |
10/05/2023 4:06 PM | Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer) Sukhtian Faisal Ghiath (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/05/2023 4:07 PM | Haddadin Yezan Munther (Reporting) Outlook Therapeutics, Inc. (Issuer) Outlook Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |